Group 1 - The board of directors of Jiangsu Lianhuan Pharmaceutical Co., Ltd. held its 11th temporary meeting of the 9th session on July 15, 2025, via communication method, which was legally convened and valid [1] - The board approved the proposal for the construction of new export formulation factory buildings, new anti-tumor synthesis factory buildings, and anti-tumor formulation factory buildings and production lines, with a unanimous vote of 9 in favor [1] - The board also approved the proposal for the construction of a new export formulation drug production line and a three-dimensional warehouse project by its wholly-owned subsidiary Yangzhou Pharmaceutical, with 8 votes in favor and one related director abstaining from the vote [2]